Castle Biosciences Inc (CSTL): Total Assets
$578.56M
As of 2025-12-31
$561.18M
As of 2026-06-30
+9.0%
3-year compound annual growth
+5.7%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $578.56M | +8.9% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $531.24M | +17.2% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $453.34M | +1.3% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $447.33M | -3.3% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $462.57M | +5.3% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $439.33M | +266.9% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $119.75M | +434.5% | 2021-03-11, Balance as of period end |
| 2018-12-31 | $22.41M | n/a | 2020-03-10, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $578.56M | +8.9% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $1.21B | -0.5% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $413.23M | -15.8% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $632.65M | +109.4% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $1.41B | +8.2% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $2.92B | -2.1% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $1.13B | +227.5% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $2.01B | +35.5% |
| Biodesix Inc (BDSX) | 2025-12-31 | $87.48M | -10.0% |
Compare CSTL, FLGT, CDNA, BLLN side by side · Screen every company in Services-Medical Laboratories ↗